Skip to content

Internet - Based Shamiri Single Session Intervention

The Shamiri Single Session Digital Intervention for Adolescent Anxiety and Depression: A Randomized Control Trial of an Internet - Based Intervention in a Low-resourced School in Kenya

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
PACTR
Registry ID
PACTR201906810558181
Enrollment
130
Registered
2019-06-21
Start date
2019-06-21
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Mental and Behavioural Disorders

Interventions

Shamiri Digital Intervention Group
Shamiri Digital Study Skills

Sponsors

Tom Osborn
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Participants must be aged between 13 and 18.

Exclusion criteria

Exclusion criteria: There is no exclusion criteria for any participant who meets the inclusion criteria.

Design outcomes

Primary

MeasureTime frame
Changes in self-reported depression symptoms as measured by the Patient Health Questionnaire - 8 ;Changes in self-reported anxiety symptoms, measured by the Generalized Anxiety Disorder Screener - 7;Changes in self-reported mental well-being as indicated by the The Short Warwick–Edinburgh Mental Well-being Scale (SWEMWBS)

Secondary

MeasureTime frame
Changes in perceived academic control, measured by the Perceived Control Scale for Children - Academic sub scale. ;Changes in self-reported optimism, as measured by the EPOCH Measure of Adolescent Well-Being - Optimism sub scale;Changes in self-reported happiness, as measured by the EPOCH Measure of Adolescent Well-Being - Happiness subscale.;Changes in self-reported depression symptoms as measured by the PHQ-8 for participants who meet a clinical cut-off for depression and anxiety symptoms - clinical cutoff will be determined by a score of 10 or greater on the GAD-7 or a score of 15 or greater on the PHQ-8;Changes in self-reported anxiety symptoms as measured by the GAD-7 for participants who meet a clinical cut-off for depression and anxiety symptoms - clinical cutoff will be determined by a score of 10 or greater on the GAD-7 or a score of 15 or greater on the PHQ-8;Moderator analysis on primary outcomes with level of anxiety symptoms as a continuous moderator.;Moderator analysis on primary outcomes with level of depression symptoms as a continuous moderator.;Moderator analysis on primary outcomes with level of anxiety symptoms as a categorical moderator - categories will be no-anxiety, 0-4 on GAD-7, mild-anxiety, 5-9 on the GAD-7, and moderate-to-severe anxiety, 10 or greater on the GAD - 7 .;Moderator analysis on primary outcomes with level of depression symptoms as a categorical moderator - categories will be defined as minimal-or-none depression, defined as 0-4 on the PHQ-8, mild depression, defined as 5-9 on the PHQ-8, moderate depression, defined as 10-14 on the PHQ-8, moderately severe-to-severe depression, defined as greater than 15 on the PHQ-8.

Countries

Kenya

Contacts

Public ContactTom;Rediet Osborn;Alemu

Principal Investigator;Co Investigator

osborn@shamiri.institute;rediet@shamiri.institute+25475612145;+251923590095

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Aug 9, 2026